SCHEMBL31729239

SCHEMBL31729239

Nc1ncnc2c(-c3cccc(Cl)c3Cl)cc(N3CCOCC3)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 8/20 0.53
▸ DGAT1 O75907 1/20 0.46
▸ LRRK2 Q5S007 1/20 0.41
▸ PIK3R2 O00459 4/20 0.40
▸ PIK3C3 Q8NEB9 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ PPARG P37231 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NCOA2 Q15596 1/20 0.40
▸ NCOA1 Q15788 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ PIK3R1 P27986 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ ADK P55263 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31727998 0.89 MAP4K4 (0.49) CNR2DGAT1PTPN11
SCHEMBL31729166 0.83 PIK3C3 (0.47) CNR2DGAT1LRRK2PIK3R2PIK3C3
SCHEMBL31728357 0.83 PIK3C3 (0.47) CNR2DGAT1LRRK2PIK3R2PIK3C3
SCHEMBL31728894 0.83 PTPN11 (0.41) CNR2DGAT1PTPN11
SCHEMBL31727887 0.83 STK4 (0.53) CNR2LRRK2PIK3R2ADK
SCHEMBL31728602 0.79 CNR2 (0.49) CNR2DGAT1ALDH1A1PTPN11
SCHEMBL31729125 0.77 DGAT1 (0.38) DGAT1KDM4EPIK3CDPTPN11
SCHEMBL31728080 0.76 NOTUM (0.39) DGAT1MEN1KMT2ATDP1
SCHEMBL31728633 0.75 MAP4K4 (0.41) DGAT1
SCHEMBL31727873 0.75 SMN1; SMN2 (0.40) DGAT1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback